Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene

Archives of Biochemistry and Biophysics
H WangG S Yost

Abstract

Members of the CYP2F gene subfamily are selectively expressed in lung tissues and have been implicated as important catalysts in the formation of reactive intermediates from several pneumotoxic chemicals. Human CYP2F1 bioactivates 3-methylindole (3MI), while mouse CYP2F2 bioactivates naphthalene. Although 3MI is a potent pneumotoxin in ruminants and rodents, the participation of cytochrome P450s from the 2F subfamily in 3MI bioactivation has not been fully defined. To test the hypothesis that a goat lung 2F homologue uniquely catalyzes the dehydrogenation of 3MI to the putative electrophile 3-methylene-indolenine, the CYP2F3 cDNA was cloned from a goat lung cDNA library and expressed in Escherichia coli. The predicted amino acid sequence of CYP2F3 possessed 82% identity to both human CYP2F1 and mouse CYP2F2. CYP2F3 was mutated at the 5' end, expressed in E. coli, and shown to have a molecular mass of 50 kDa. The reconstituted enzyme uniquely catalyzed only the dehydrogenation of 3MI to form 3-methylene-indolenine, an electrophilic intermediate, without detectable formation of other products, thus demonstrating highly unusual selectivity for dehydrogenation rather than hydroxylation of a substrate. Immunoinhibition studies demon...Continue Reading

References

Dec 8, 1992·Biochimica Et Biophysica Acta·D K Winters, A I Cederbaum
Sep 1, 1992·Trends in Pharmacological Sciences·F J Gonzalez
Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·H J BarnesM R Waterman
Jul 1, 1991·Chemical Research in Toxicology·F P Guengerich, T Shimada
Nov 27, 1991·Biochemical and Biophysical Research Communications·J R Thornton-ManningG S Yost
Sep 1, 1989·Chemical Research in Toxicology·G S Yost
Jan 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·O W McBrideD Givol
Oct 1, 1985·Analytical Biochemistry·P K SmithD C Klenk
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·G M Church, W Gilbert
Jan 1, 1994·CA: a Cancer Journal for Clinicians·C C BoringS Montgomery
Aug 15, 1993·Archives of Biochemistry and Biophysics·E M GillamF P Guengerich
Jan 1, 1996·Chemical Research in Toxicology·G L Skiles, G S Yost

❮ Previous
Next ❯

Citations

Aug 21, 2012·Chemical Research in Toxicology·James B Y H BehrendorffElizabeth M J Gillam
Aug 25, 2009·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jessica M WeemsGarold S Yost
Feb 24, 2000·American Journal of Veterinary Research·J LakritzC G Plopper
Feb 18, 2015·Drug Metabolism Reviews·Jolantha BeyerleCornelia M Ulrich
Dec 19, 2002·Drug Metabolism Reviews·A BuckpittC Plopper
Mar 1, 2007·Mutation Research·Gilles TournelJean-Marc Lo-Guidice
Aug 1, 2006·Biochemical and Biophysical Research Communications·Mary Beth GenterDaniel W Nebert
Aug 23, 2005·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Shosaku KashiwadaSeth W Kullman
Dec 21, 2006·Toxicologic Pathology·Alan M JeffreyGary M Williams
Jul 12, 2017·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Shotaro UeharaHiroshi Yamazaki
May 5, 2004·The Journal of Pharmacology and Experimental Therapeutics·Andrea C SimmondsPoh-Gek Forkert
Oct 29, 2004·The Journal of Pharmacology and Experimental Therapeutics·R Michael BaldwinAlan R Buckpitt
Apr 16, 2003·Molecular Pharmacology·Brian A CarrGarold S Yost
Feb 21, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Gwyn PakenhamAlan Buckpitt
Apr 30, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jie WanGarold S Yost
Jul 1, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Poh-Gek ForkertKathy S Collins
Apr 22, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·G VirkelC Lanusse
Apr 16, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Stephanie L BornMichael P Purdon
Dec 11, 2007·Chemical Research in Toxicology·Elizabeth M J Gillam
Nov 24, 1999·Biochemical and Biophysical Research Communications·E M GillamF P Guengerich
Jul 10, 2003·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Arja AsikainenRisto O Juvonen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.